Efficacy and Safety of TACE in Combination With Sorafenib for the Treatment of TACE-refractory Advanced Hepatocellular Carcinoma in Chinese Patients: A Retrospective Study
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s131022
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2017
Authors
Publisher
Informa UK Limited